Structure Therapeutics (GPCR) Earnings Date & Reports
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GPCR is expected to report earnings to rise 4.08% to -50 cents per share on November 05
Q3'26
Est.
$-0.51
Q2'26
Missed
by $0.12
Q1'26
Est.
$-0.35
Q4'25
Beat
by $0.45
Q3'25
Missed
by $0.10
The last earnings report on August 06 showed earnings per share of -49 cents, missing the estimate of -37 cents. With 171.82K shares outstanding, the current market capitalization sits at 1.57B.